Literature DB >> 22392523

Estimating utilities for chronic kidney disease, using SF-36 and SF-12-based measures: challenges in a population of veterans with diabetes.

Mangala Rajan1, Kuan-Chi Lai, Chin-Lin Tseng, Shirley Qian, Alfredo Selim, Lewis Kazis, Leonard Pogach, Anushua Sinha.   

Abstract

PURPOSE: Using transformations of existing quality-of-life data to estimate utilities has the potential to efficiently provide investigators with utility information. We used within-method and across-method comparisons and estimated disutilities associated with increasing chronic kidney disease (CKD) severity.
METHODS: In an observational cohort of veterans with diabetes (DM) and pre-existing SF-36/SF-12 responses, we used six transformation methods (SF-12 to EQ-5D, SF-36 to HUI2, SF-12 to SF-6D, SF-36 to SF-6D, SF-36 to SF-6D (Bayesian method), and SF-12 to VR-6D) to estimate unadjusted utilities. CKD severity was staged using glomerular filtration rate estimated from serum creatinines, with the modification of diet in renal disease formula. We then used multivariate regression to estimate disutilities specifically associated with CKD severity stage.
RESULTS: Of 67,963 patients, 22,273 patients had recent-onset DM and 45,690 patients had prevalent DM. For the recent-onset group, the adjusted disutility associated with CKD derived from the six transformation methods ranged from 0.0029 to 0.0045 for stage 2; -0.004 to -0.0009 for early stage 3; -0.017 to -0.010 for late stage 3; -0.023 to -0.012 for stage 4; -0.078 to -0.033 for stage 5; and -0.012 to -0.001 for ESRD/dialysis.
CONCLUSION: Disutility did not increase monotonically as CKD severity increased. Differences in disutilities estimated using the six different methods were found. Both findings have implications for using such estimates in economic analyses.

Entities:  

Mesh:

Year:  2012        PMID: 22392523     DOI: 10.1007/s11136-012-0139-1

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  55 in total

1.  The relationship between health-state utilities and the SF-12 in a general population.

Authors:  L Lundberg; M Johannesson; D G Isacson; L Borgquist
Journal:  Med Decis Making       Date:  1999 Apr-Jun       Impact factor: 2.583

2.  The practicality and validity of directly elicited and SF-36 derived health state preferences in patients with low back pain.

Authors:  William Hollingworth; Richard A Deyo; Sean D Sullivan; Scott S Emerson; Darryl T Gray; Jeffrey G Jarvik
Journal:  Health Econ       Date:  2002-01       Impact factor: 3.046

3.  The estimation of a preference-based measure of health from the SF-36.

Authors:  John Brazier; Jennifer Roberts; Mark Deverill
Journal:  J Health Econ       Date:  2002-03       Impact factor: 3.883

4.  Evaluating quality-adjusted life years: estimation of the health utility index (HUI2) from the SF-36.

Authors:  M B Nichol; N Sengupta; D R Globe
Journal:  Med Decis Making       Date:  2001 Mar-Apr       Impact factor: 2.583

5.  The transient nature of utilities and health preferences.

Authors:  Olga Kostopoulou
Journal:  Med Decis Making       Date:  2006 Jul-Aug       Impact factor: 2.583

6.  Comparing SF-6D and EQ-5D utilities across groups differing in health status.

Authors:  Nick Kontodimopoulos; Evelina Pappa; Angelos A Papadopoulos; Yannis Tountas; Dimitris Niakas
Journal:  Qual Life Res       Date:  2008-11-29       Impact factor: 4.147

7.  Estimating glomerular filtration rate.

Authors:  W Greg Miller
Journal:  Clin Chem Lab Med       Date:  2009       Impact factor: 3.694

8.  Comparison of valuation methods used to generate the EQ-5D and the SF-6D value sets.

Authors:  Aki Tsuchiya; John Brazier; Jennifer Roberts
Journal:  J Health Econ       Date:  2005-11-04       Impact factor: 3.883

9.  Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence.

Authors:  James P Boyle; Theodore J Thompson; Edward W Gregg; Lawrence E Barker; David F Williamson
Journal:  Popul Health Metr       Date:  2010-10-22

10.  Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial.

Authors:  Paul Glasziou; Jan Alexander; Elaine Beller; Philip Clarke
Journal:  Health Qual Life Outcomes       Date:  2007-04-27       Impact factor: 3.186

View more
  4 in total

1.  Comparison of the preference-based EQ-5D-5L and SF-6D in patients with end-stage renal disease (ESRD).

Authors:  Fan Yang; Titus Lau; Evan Lee; A Vathsala; Kee Seng Chia; Nan Luo
Journal:  Eur J Health Econ       Date:  2014-12-18

2.  Substitution of SF-36 by SF-12 Among Hong Kong Chinese Older Adults: Secondary Analysis of Randomized Controlled Trials.

Authors:  Paul H Lee; Frances K Y Wong; Shao Ling Wang; Susan K Y Chow
Journal:  Int J Behav Med       Date:  2016-10

3.  Population level outcomes and cost-effectiveness of hepatitis C treatment pre- vs postkidney transplantation.

Authors:  Brittany A Shelton; Deirdre Sawinski; Benjamin P Linas; Peter P Reese; Margaux Mustian; Mitch Hungerpiller; Rhiannon D Reed; Paul A MacLennan; Jayme E Locke
Journal:  Am J Transplant       Date:  2018-08-30       Impact factor: 9.369

Review 4.  Economic Modelling of Chronic Kidney Disease: A Systematic Literature Review to Inform Conceptual Model Design.

Authors:  Daniel M Sugrue; Thomas Ward; Sukhvir Rai; Phil McEwan; Heleen G M van Haalen
Journal:  Pharmacoeconomics       Date:  2019-12       Impact factor: 4.981

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.